Canada (CA)

Solution-based intramolecular singlet fission in cross-conjugated pentacene dimers (2016) Zirzlmeier J, Casillas R, Reddy R, Coto PB, Lehnherr D, Chernick E, Papadopoulos I, et al. Journal article Unexpected Michael Additions on the Way to 2.3,8.9-Dibenzanthanthrenes with Interesting Structural Properties (2016) Reus C, Lechner M, Schulze M, Lungerich D, Diner C, Gruber M, Stryker JM, et al. Journal article Insights into the pore structure of KIT-6 and SBA-15 ordered mesoporous silica - recent advances by combining physical adsorption with mercury porosimetry. (2016) Guillet-Nicolas R, Ahmad R, Cychosz KA, Kleitz F, Thommes M Journal article, Original article Long-Term (156-Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of 3 Phase III, Randomized, Controlled Trials (2016) Mease PJ, Gladman DD, Gomez-Reino JJ, Hall S, Kavanaugh A, Lespessailles E, Schett G, et al. Conference contribution Apremilast Treatment and Long-Term (156-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Analysis of a Large Database of 3 Phase III, Randomized, Controlled Trials (2016) Gladman DD, Kavanaugh A, Gomez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, et al. Conference contribution APREMILAST, AN ORAL PHOSPHODIESTERASE-4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (104-WEEK) IMPROVEMENTS IN ENTHESITIS AND DACTYLITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM THREE PHASE III RANDOMIZED CONTROLLED TRIALS (2016) Gladman DD, Kavanaugh A, Adebajo AO, Gomez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, et al. Conference contribution Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-term (104-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III, Randomized, Controlled Trials (2016) Gladman D, Kavanaugh A, Adebajo A, Gomez-Reino J, Wollenhaupt J, Cutolo M, Schett G, et al. Conference contribution THE EUROPEAN SOCIAL PREFERENCE MEASUREMENT (ESPM) STUDY: CONCEPTUAL CONSIDERATIONS AND IMPLEMENTATION (2016) Schlander M, Telser H, Holm S, Marshall DA, Nord E, Richardson J, Garattini S, et al. Conference contribution Comparison between core-lab and site-read assessment of coronary CT angiography for detection of ischemia-causing lesions: a substudy of the NXT trial (2016) Marwan M, Gaur S, Leipsic J, Seneviratne S, Ito H, Mauri L, De Bruyne B, et al. Conference contribution The ratio of coronary arterial lumen volume to left ventricle mass identifies patients with nonobstructive coronary artery disease having vessel-specific ischemia measured by fractional flow reserve (2016) Taylor C, Gaur S, Khem S, Kim HJ, Wilk A, Zarins CK, Achenbach S, et al. Conference contribution